 Evolent Health NYSE:EVH had its price target upped by SunTrust Banks from 14.00 to 15.00 in a report released on Monday, BenzingaRatingsTable reports. The brokerage currently has a buy rating on the technology companys stock. Other analysts have also issued reports about the stock. Canaccord Genuity reissued a buy rating and set a 13.00 price ... 